Richard H. Myers, PhD
Professor Emeritus
Boston University Chobanian & Avedisian School of Medicine

PhD, Georgia State University
MA, Georgia State University
MEd, Georgia State University
BA, University of Kansas

Dr. Richard H. Myers retired in 2020 and is now Emeritus Professor of Neurology at Chobanian and Avedisian School of Medicine. He is no longer accepting students or post-doctoral fellows. The phone number listed in my contact information is not active. I no longer have a phone at BUSM.

Dr. Myers' professional interests focused upon the application of genetic research methods for the investigation of adult onset diseases with complex etiology (Parkinson’s disease, coronary heart disease, Alzheimer’s disease, pulmonary function, osteoarthritis, osteoporosis etc.). Dr. Myers has had a long-standing interest in Huntington’s disease and has participated in a wide range of research investigations for this disease. He was a member of the New England Huntington’s disease "Center Without Walls" since its inception in 1980. His HD studies are best characterized as ‘Neurobiological Studies’ in that they include studies into the mechanisms of disease expression, including complex genetic modifier studies and a series of neuropathological studies of effects of disease expression in the brain. Additional interests include ethical issues influencing utilization of genetic test procedures.
Dr. Myers been involved in a number of studies in positional cloning. He also participated in the cloning of the gene for Huntington’s disease in 1993. He initiated the genome scan project in the Framingham Study, and a genome scan in Parkinson’s disease. Dr. Myers' Parkinson’s disease genetic linkage study, known as the "GenePD" study, involved an international collaboration of twenty clinical centers in Parkinson’s disease. The study sought genetic loci involved in risk for PD. From 1993 he has participated in genetic linkage studies for hypertension (the HyperGEN study, one of the NHLBI Family Blood Pressure Program Project studies), and the genome scan in the NHLBI Family Heart Study.

Dr. Myers has published more than 250 peer reviewed articles, 38 individual NIH funded grants, and mentored many extraordinarily talented students and post-docs.

Boston Medical Center

Cyclin G-associated kinase as a novel target for Parkinson's disease
01/01/2017 - 12/31/2019 (PI)
Ellison Foundation

Functional analysis of Disease associated risk alleles in sporadic Parkinson's disease
09/23/2014 - 06/30/2019 (Multi-PI)
PI: Richard H. Myers, PhD
Whitehead Institute for Biomedical Research NIH NINDS

Probing the Dark Matter of the Genome in the NHLBI Family Heart Study
07/01/2016 - 06/30/2018 (Subcontract PI)
The Washington University NIH NHLBI

Epigenetic Markers in Huntington's Disease Brain
07/01/2011 - 04/30/2017 (PI)
NIH/National Institute of Neurological Disorders & Stroke

Probing the Dark Matter of the Genome in the NHLBI Family Heart Study
07/22/2013 - 06/30/2016 (Subcontract PI)
The Washington University NIH NHLBI

Epigenetic Markers of Huntington Disease Brain
07/01/2011 - 04/30/2016 (PI)
NIH/National Institute of Neurological Disorders & Stroke
1 R01 NS073947 01

Characterization of the role of cyclin G-associated kinase in Parkinson disease
09/01/2011 - 04/30/2015 (PI)
NIH/National Institute of Neurological Disorders & Stroke

Genomic Scan for Atherosclerosis Pathway Genes in African Americans from FHS Scan
05/15/2008 - 04/30/2013 (Subcontract PI)
The Washington University NIH NHLBI

Identifying Susceptibility Genes for Metabolic Syndrome
01/29/2007 - 12/31/2011 (Subcontract PI)
Regents of the University of Minnesota NIH NIDDK

Mapping Adiposity QTLs in the NHLBI Family Heart Study
09/20/2004 - 06/30/2009 (PI)
Washington University, St Louis NIH NIDDK

Showing 10 of 12 results. Show All Results


Yr Title Project-Sub Proj Pubs
2018 An iPSC based platform for functionally assessing genetic and environmental risk 5R01NS088538-05 32
2017 An iPSC based platform for functionally assessing genetic and environmental risk 5R01NS088538-04 32
2016 An iPSC based platform for functionally assessing genetic and environmental risk 5R01NS088538-03 32
2015 An iPSC based platform for functionally assessing genetic and environmental risk 5R01NS088538-02 32
2015 Epigenetic Markers in Huntington's disease Brain 5R01NS073947-05 33
2015 Epigenetic Markers in Huntington's disease Brain 3R01NS073947-05S1 33
2014 An iPSC based platform for functionally assessing genetic and environmental risk 1R01NS088538-01 32
2014 Epigenetic Markers in Huntington's disease Brain 5R01NS073947-04 33
2013 Characterization of the role of cyclin G-associated kinase in Parkinson disease 5R01NS076843-03 14
2013 Epigenetic Markers in Huntington's disease Brain 5R01NS073947-03 33
Showing 10 of 34 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Nazeen S, Wang X, Zielinski D, Lam I, Hallacli E, Xu P, Ethier E, Strom R, Zanella CA, Nithianandam V, Ritter D, Henderson A, Saurat N, Afroz J, Nutter-Upham A, Benyamini H, Copty J, Ravishankar S, Morrow A, Mitchel J, Neavin D, Gupta R, Farbehi N, Grundman J, Myers RH, Scherzer CR, Trojanowski JQ, Van Deerlin VM, Cooper AA, Lee EB, Erlich Y, Lindquist S, Peng J, Geschwind DH, Powell J, Studer L, Feany MB, Sunyaev SR, Khurana V. Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies. bioRxiv. 2024 Mar 07. PMID: 38496508; PMCID: PMC10942362; DOI: 10.1101/2024.03.03.583145;
  2. Hyeon SJ, Park J, Yoo J, Kim SH, Hwang YJ, Kim SC, Liu T, Shim HS, Kim Y, Cho Y, Woo J, Kim KS, Myers RH, Ryu HL, Kowall NW, Song EJ, Hwang EM, Seo H, Lee J, Ryu H. Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntington's disease. Prog Neurobiol. 2021 09; 204:102110.View Related Profiles. PMID: 34166773; PMCID: PMC8364511; DOI: 10.1016/j.pneurobio.2021.102110;
  3. Lai D, Alipanahi B, Fontanillas P, Schwantes-An TH, Aasly J, Alcalay RN, Beecham GW, Berg D, Bressman S, Brice A, Brockman K, Clark L, Cookson M, Das S, Van Deerlin V, Follett J, Farrer MJ, Trinh J, Gasser T, Goldwurm S, Gustavsson E, Klein C, Lang AE, Langston JW, Latourelle J, Lynch T, Marder K, Marras C, Martin ER, McLean CY, Mejia-Santana H, Molho E, Myers RH, Nuytemans K, Ozelius L, Payami H, Raymond D, Rogaeva E, Rogers MP, Ross OA, Samii A, Saunders-Pullman R, Schüle B, Schulte C, Scott WK, Tanner C, Tolosa E, Tomkins JE, Vilas D, Trojanowski JQ, Uitti R, Vance JM, Visanji NP, Wszolek ZK, Zabetian CP, Mirelman A, Giladi N, Orr Urtreger A, Cannon P, Fiske B, Foroud T. Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease. Ann Neurol. 2021 07; 90(1):76-88.View Related Profiles. PMID: 33938021; PMCID: PMC8252519; DOI: 10.1002/ana.26094;
  4. Raghunathan R, Hogan JD, Labadorf A, Myers RH, Zaia J. A glycomics and proteomics study of aging and Parkinson's disease in human brain. Sci Rep. 2020 07 30; 10(1):12804.View Related Profiles. PMID: 32733076; PMCID: PMC7393382; DOI: 10.1038/s41598-020-69480-3;
  5. Ellis N, Tee A, McAllister B, Massey T, McLauchlan D, Stone T, Correia K, Loupe J, Kim KH, Barker D, Hong EP, Chao MJ, Long JD, Lucente D, Vonsattel JPG, Pinto RM, Elneel KA, Ramos EM, Mysore JS, Gillis T, Wheeler VC, Medway C, Hall L, Kwak S, Sampaio C, Ciosi M, Maxwell A, Chatzi A, Monckton DG, Orth M, Landwehrmeyer GB, Paulsen JS, Shoulson I, Myers RH, van Duijn E, Rickards H, MacDonald ME, Lee JM, Gusella JF, Jones L, Holmans P. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease. Biol Psychiatry. 2020 05 01; 87(9):857-865. PMID: 32087949; PMCID: PMC7156911; DOI: 10.1016/j.biopsych.2019.12.010;
  6. Agus F, Crespo D, Myers RH, Labadorf A. The caudate nucleus undergoes dramatic and unique transcriptional changes in human prodromal Huntington's disease brain. BMC Med Genomics. 2019 10 16; 12(1):137.View Related Profiles. PMID: 31619230; PMCID: PMC6796419; DOI: 10.1186/s12920-019-0581-9;
  7. Wyss AB, Sofer T, Lee MK, Terzikhan N, Nguyen JN, Lahousse L, Latourelle JC, Smith AV, Bartz TM, Feitosa MF, Gao W, Ahluwalia TS, Tang W, Oldmeadow C, Duan Q, de Jong K, Wojczynski MK, Wang XQ, Noordam R, Hartwig FP, Jackson VE, Wang T, Obeidat M, Hobbs BD, Huan T, Gui H, Parker MM, Hu D, Mogil LS, Kichaev G, Jin J, Graff M, Harris TB, Kalhan R, Heckbert SR, Paternoster L, Burkart KM, Liu Y, Holliday EG, Wilson JG, Vonk JM, Sanders JL, Barr RG, de Mutsert R, Menezes AMB, Adams HHH, van den Berge M, Joehanes R, Levin AM, Liberto J, Launer LJ, Morrison AC, Sitlani CM, Celedón JC, Kritchevsky SB, Scott RJ, Christensen K, Rotter JI, Bonten TN, Wehrmeister FC, Bossé Y, Xiao S, Oh S, Franceschini N, Brody JA, Kaplan RC, Lohman K, McEvoy M, Province MA, Rosendaal FR, Taylor KD, Nickle DC, Williams LK, Burchard EG, Wheeler HE, Sin DD, Gudnason V, North KE, Fornage M, Psaty BM, Myers RH, O'Connor G, Hansen T, Laurie CC, Cassano PA, Sung J, Kim WJ, Attia JR, Lange L, Boezen HM, Thyagarajan B, Rich SS, Mook-Kanamori DO, Horta BL, Uitterlinden AG, Im HK, Cho MH, Brusselle GG, Gharib SA, Dupuis J, Manichaikul A, London SJ. Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function. Nat Commun. 2018 07 30; 9(1):2976.View Related Profiles. PMID: 30061609; PMCID: PMC6065313; DOI: 10.1038/s41467-018-05369-0;
  8. Labadorf A, Choi SH, Myers RH. Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles. Front Mol Neurosci. 2017; 10:430.View Related Profiles. PMID: 29375298; PMCID: PMC5768647; DOI: 10.3389/fnmol.2017.00430;
  9. Hui KY, Fernandez-Hernandez H, Hu J, Schaffner A, Pankratz N, Hsu NY, Chuang LS, Carmi S, Villaverde N, Li X, Rivas M, Levine AP, Bao X, Labrias PR, Haritunians T, Ruane D, Gettler K, Chen E, Li D, Schiff ER, Pontikos N, Barzilai N, Brant SR, Bressman S, Cheifetz AS, Clark LN, Daly MJ, Desnick RJ, Duerr RH, Katz S, Lencz T, Myers RH, Ostrer H, Ozelius L, Payami H, Peter Y, Rioux JD, Segal AW, Scott WK, Silverberg MS, Vance JM, Ubarretxena-Belandia I, Foroud T, Atzmon G, Pe'er I, Ioannou Y, McGovern DPB, Yue Z, Schadt EE, Cho JH, Peter I. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease. Sci Transl Med. 2018 01 10; 10(423). PMID: 29321258; PMCID: PMC6028002; DOI: 10.1126/scitranslmed.aai7795;
  10. Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS, Myers RH. MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study. Neurology. 2018 01 23; 90(4):e264-e272.View Related Profiles. PMID: 29282329; PMCID: PMC5798654; DOI: 10.1212/WNL.0000000000004844;
Showing 10 of 345 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 340 publications over 42 distinct years, with a maximum of 17 publications in 2002


In addition to these self-described keywords below, a list of MeSH based concepts is available here.

coronary heart disease
genetic testing
Huntington's disease
Parkinson's disease
risk factors
Contact for Mentoring:

75 E. Newton St Evans Building
Boston MA 02118
Google Map

Myers's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department